113 related articles for article (PubMed ID: 24004297)
21. [A mammographic evaluation of the morphostructural variations of the breast during hormone-replacement therapy in the postmenopause].
Porfiri LM; Costanza L; De Felice C; Perrone G; David V; Zichella L
Radiol Med; 1998 Jun; 95(6):573-6. PubMed ID: 9717537
[TBL] [Abstract][Full Text] [Related]
22. Influence of lifestyle factors on mammographic density in postmenopausal women.
Brand JS; Czene K; Eriksson L; Trinh T; Bhoo-Pathy N; Hall P; Celebioglu F
PLoS One; 2013; 8(12):e81876. PubMed ID: 24349146
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous estradiol/oral micronized progesterone has less-adverse effects and different gene regulations than oral conjugated equine estrogens/medroxyprogesterone acetate in the breasts of healthy women in vivo.
Murkes D; Lalitkumar PG; Leifland K; Lundström E; Söderqvist G
Gynecol Endocrinol; 2012 Oct; 28 Suppl 2():12-5. PubMed ID: 22834417
[TBL] [Abstract][Full Text] [Related]
24. Hormone replacement therapy and breast density changes.
Harvey J; Scheurer C; Kawakami FT; Quebe-Fehling E; de Palacios PI; Ragavan VV
Climacteric; 2005 Jun; 8(2):185-92. PubMed ID: 16096175
[TBL] [Abstract][Full Text] [Related]
25. Mammographic density in women on postmenopausal hormone replacement therapy.
Leung W; Goldberg F; Zee B; Sterns E
Surgery; 1997 Oct; 122(4):669-73; discussion 673-4. PubMed ID: 9347841
[TBL] [Abstract][Full Text] [Related]
26. The relationship between estrogen receptor gene polymorphism and mammographic density in postmenopausal women.
Baldisserotto FD; Elias S; Silva ID; Nazario AC
Climacteric; 2013 Jun; 16(3):369-80. PubMed ID: 23078272
[TBL] [Abstract][Full Text] [Related]
27. [Monitoring the breast changes of Chinese postmenopausal women under long-term hormone replacement therapy by mammary ultrasonography].
Huang MT; Jiang YX; Lin SQ; Zhang Y; Zhou YZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):24-9. PubMed ID: 15052769
[TBL] [Abstract][Full Text] [Related]
28. High volumetric breast density predicts risk for breast cancer in postmenopausal, but not premenopausal, Korean Women.
Park IH; Ko K; Joo J; Park B; Jung SY; Lee S; Kwon Y; Kang HS; Lee ES; Lee KS; Ro J
Ann Surg Oncol; 2014 Dec; 21(13):4124-32. PubMed ID: 24934582
[TBL] [Abstract][Full Text] [Related]
29. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern.
Laya MB; Gallagher JC; Schreiman JS; Larson EB; Watson P; Weinstein L
Radiology; 1995 Aug; 196(2):433-7. PubMed ID: 7617857
[TBL] [Abstract][Full Text] [Related]
30. Case-control study of increased mammographic breast density response to hormone replacement therapy.
Vachon CM; Sellers TA; Vierkant RA; Wu FF; Brandt KR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1382-8. PubMed ID: 12433715
[TBL] [Abstract][Full Text] [Related]
31. Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women.
Stuedal A; Ma H; Bjørndal H; Ursin G
Climacteric; 2009 Jun; 12(3):248-58. PubMed ID: 19387884
[TBL] [Abstract][Full Text] [Related]
32. Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection.
Chiarelli AM; Prummel MV; Muradali D; Shumak RS; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ
Breast Cancer Res Treat; 2015 Nov; 154(2):377-87. PubMed ID: 26518019
[TBL] [Abstract][Full Text] [Related]
33. Mammographic and ultrasonographic study of changes in the breast related to HRT.
Ozdemir A; Konuş O; Nas T; Erbaş G; Coşar S; Işik S
Int J Gynaecol Obstet; 1999 Oct; 67(1):23-32. PubMed ID: 10576236
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
[TBL] [Abstract][Full Text] [Related]
35. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
36. Effect of estrogen-progestin and estrogen on mammographic density.
Kaewrudee S; Anuwutnavin S; Kanpittaya J; Soontrapa S; Sakondhavat C
J Reprod Med; 2007 Jun; 52(6):513-20. PubMed ID: 17694969
[TBL] [Abstract][Full Text] [Related]
37. The effect of transdermal testosterone on mammographic density in postmenopausal women not receiving systemic estrogen therapy.
Davis SR; Hirschberg AL; Wagner LK; Lodhi I; von Schoultz B
J Clin Endocrinol Metab; 2009 Dec; 94(12):4907-13. PubMed ID: 19850682
[TBL] [Abstract][Full Text] [Related]
38. Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density.
Lundström E; Bygdeson M; Svane G; Azavedo E; von Schoultz B
Climacteric; 2007 Jun; 10(3):249-56. PubMed ID: 17487652
[TBL] [Abstract][Full Text] [Related]
39. Less mammographic density after nasal versus oral administration of postmenopausal hormone therapy.
van Dijck JA; Otten JD; Karssemeijer N; Kenemans P; Verbeek AL; van der Mooren MJ
Climacteric; 2011 Dec; 14(6):683-8. PubMed ID: 21942620
[TBL] [Abstract][Full Text] [Related]
40. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
Ursin G; Palla SL; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Greendale GA
J Clin Oncol; 2004 Jul; 22(14):2842-8. PubMed ID: 15254051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
